Acute myeloid leukemia patient with active disseminated tuberculosis bridged to transplant with reduced 14-day venetoclax and azacitidine schedule

Theresa Lentner*, Gerhard Krajnik

*Corresponding author for this work

Research output: Journal article (peer-reviewed)Case report

Fingerprint

Dive into the research topics of 'Acute myeloid leukemia patient with active disseminated tuberculosis bridged to transplant with reduced 14-day venetoclax and azacitidine schedule'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry